Condition: Advanced Solid Tumor · Metastatic Solid Tumor · Sponsor: BeOne Medicines
The goal of this clinical trial is to learn if BGB-B455 can treat advanced or metastatic solid tumors expressing claudin 6 (CLDN6), a protein that is found on some tumors. The main questions it aims to answer are: * What is the recommended dosing for BGB-B455? * What medical problems do participants have when taking BGB-B455? The study has two parts: * Phase 1a: dose escalation and safety expansion * Phase 1b: dose expansion
This description comes directly from the study's public registry record.
Study Director · 1.877.828.5568 · clinicaltrials@beonemed.com
Always discuss trial participation with your own doctor first.
| Adventhealth | Celebration, Florida, United States | Recruiting |
| Sidney Kimmel Cancer Center | Philadelphia, Pennsylvania, United States | Recruiting |
| Avera Cancer Institute | Sioux Falls, South Dakota, United States | Recruiting |
| Next Oncology | San Antonio, Texas, United States | Recruiting |
| Fred Hutchinson Cancer Research Center | Seattle, Washington, United States | Recruiting |
| Blacktown Cancer and Haematology Centre | Blacktown, New South Wales, Australia | Recruiting |
| Liverpool Hospital | Liverpool, New South Wales, Australia | Recruiting |
| Mater Cancer Care Centre | South Brisbane, Queensland, Australia | Terminated |
| Beijing Cancer Hospital | Beijing, Beijing Municipality, China | Completed |
| Sun Yat Sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Nanchang University Branch Donghu | Nanchang, Jiangxi, China | Recruiting |
| Fudan University Shanghai Cancer Centerpudong | Shanghai, Shanghai Municipality, China | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06803680